ClearPoint Neuro Inc.
ClearPoint Neuro Inc. (CLPT): 18 pipeline candidates · ~16 mo cash runway. Updated within the last hour.
BioSniper Score
4-factor signal · derived from public data
15.8 months
D/E 3.96 · 0% dilution
N/A
18 candidates
N/A
0 buys · 6 sells (180d)
A transparent, data-derived signal for ClearPoint Neuro Inc.across cash runway, pipeline maturity & breadth, catalyst momentum and clinical/regulatory footprint. Each factor traces to tracked public filings — not an investment recommendation.
Key Financials
Market Cap
$520.6M
Cash
$36.5M
Quarterly Burn
$8.0M
Runway
15.8 mo
Revenue
$12.1M
Cash Runway vs Catalysts
Tracked catalysts land within the current projected cash runway.
Pipeline (18 candidates)
Showing 10 of 18 candidates. Sign up for full pipeline.
Institutional Holdings
Source: SEC Form 13F · as of Mar 2026Institutional holders
118
Total value held
$122.6M
| Holder | Shares | Value |
|---|---|---|
| vanguard capital management llc | 2,487,230 | $22.6M |
| blackrock, inc. | 2,082,750 | $19.0M |
| mak capital one llc | 1,901,489 | $17.3M |
| geode capital management, llc | 705,720 | $6.4M |
| state street corp | 679,819 | $6.2M |
| goldman sachs group inc | 463,617 | $4.2M |
| susquehanna international group, llp | 451,484 | $4.1M |
| brown advisory inc | 325,906 | $3.0M |
| vanguard portfolio management llc | 284,809 | $2.6M |
| millennium management llc | 231,974 | $2.1M |
Showing top 10 of 118 institutional holders of ClearPoint Neuro Inc.. Sign up for the full 13F holder list and quarter-by-quarter ownership history.
Frequently asked questions
How many drug candidates are in ClearPoint Neuro Inc.'s pipeline?
ClearPoint Neuro Inc. (CLPT) has 18 pipeline candidates tracked by BioSniper across SEC filings and clinical trial registrations.
What is ClearPoint Neuro Inc.'s cash runway?
Based on its most recent reported cash balance and quarterly burn rate, ClearPoint Neuro Inc. has approximately 15.8 months of cash runway.
What is ClearPoint Neuro Inc.'s market capitalization?
ClearPoint Neuro Inc.'s market capitalization is approximately $520.6M.
Who is the CEO of ClearPoint Neuro Inc.?
Mr. Joseph Michael Burnett is the chief executive officer of ClearPoint Neuro Inc. (CLPT).
Get the full picture on ClearPoint Neuro Inc.
Deep pipeline analysis, financial trends, AI-powered investment signals, and real-time catalyst alerts.